Elite in Scleroderma

Mandana Nikpour

St Vincent's Hospital Melbourne
Melbourne, VIC, AU 
Elite in Scleroderma
St Vincent's Hospital Melbourne
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Mandana Nikpour practices in Melbourne, Australia. Ms. Nikpour is rated as an Elite expert by MediFind in the treatment of Scleroderma. Her top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Systemic Lupus Erythematosus (SLE), Bone Marrow Transplant, and Knee Replacement.

Her clinical research consists of co-authoring 247 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 144 articles in the study of Scleroderma.

Gender
Female

Locations

St Vincent's Hospital Melbourne
Melbourne, VIC, Australia
Other Locations
50 Missenden Road, Camperdown, NSW 2050, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

246 Total Publications

"Letter to "Pathological contributors to organ damage and mortality in systemic sclerosis: A nationwide matched case-control study": Author's Reply.
"Letter to "Pathological contributors to organ damage and mortality in systemic sclerosis: A nationwide matched case-control study": Author's Reply.
Journal: Seminars in arthritis and rheumatism
Published: September 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Nikpour's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile